Plasmids bearing mammalian DNA-replication origin-enriched (ors) fragments initiate semiconservative replication in a cell-free system.
Four plasmids containing monkey (CV-1) origin-enriched sequences (ors), which we have previously shown to replicate autonomously in CV-1, COS-7 and HeLa cells (Frappier and Zannis-Hadjopoulos (1987) Proc. Natl. Acad. Sci. USA 84, 6668-6672), were found to replicate in an in vitro replication system using HeLa cell extracts. De novo site-specific initiation of replication on plasmids required the presence of an ors sequence, soluble low-salt cytosolic extract, poly(ethylene glycol), a solution containing the four standard deoxyribonucleoside triphosphates and an ATP regenerating system. The major reaction products migrated as relaxed circular and linear plasmid DNAs, both in the presence and absence of high-salt nuclear extracts. Inclusion of high-salt nuclear extract was required to obtain closed circular supercoiled molecules. Replicative intermediates migrating slower than form II and topoisomers migrating between forms II and I were also included among the replication products. Replication of the ors plasmids was not inhibited by ddTTP, an inhibitor of DNA polymerase beta and gamma, and was sensitive to aphidicolin indicating that DNA polymerase alpha and/or delta was responsible for DNA synthesis. Origin mapping experiments showed that early in the in vitro replication reaction, incorporation of nucleotides occurs preferentially at ors-containing fragments, indicating ors specific initiation of replication. In contrast, the limited incorporation of nucleotides into pBR322, was not site specific. The observed synthesis was semiconservative and appeared to be bidirectional.
Pearson
C E
CE
McGill Cancer Centre, Department of Medicine, McGill University, Montreal, Canada.
Frappier
L
L
Zannis-Hadjopoulos
M
M
D000818:Animals; D016590:Aphidicolin / Q000494:pharmacology; D002474:Cell-Free System / Q000378:metabolism; D004261:DNA Replication / Q000187:drug effects; D004262:DNA Restriction Enzymes; D054306:Dideoxynucleotides; D000882:Haplorhini; D006367:HeLa Cells; D006801:Humans; D010957:Plasmids / Q000187:drug effects; D013942:Thymine Nucleotides / Q000494:pharmacology
D054306:Dideoxynucleotides; D013942:Thymine Nucleotides; D016590:Aphidicolin; D004262:DNA Restriction Enzymes; C017216:2',3'-dideoxythymidine triphosphate